120 related articles for article (PubMed ID: 11197566)
21. Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis.
Verde CR; Simpson MI; Frigoli A; Landoni MF
J Vet Pharmacol Ther; 2001 Jun; 24(3):179-85. PubMed ID: 11442795
[TBL] [Abstract][Full Text] [Related]
22. Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis.
Główka F; Karaźniewicz-Łada M; Grześkowiak E; Rogozinska D; Romanowski W
Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):167-73. PubMed ID: 21516380
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
24. Stereospecific pharmacodynamics and pharmacokinetics of carprofen in the dog.
McKellar QA; Delatour P; Lees P
J Vet Pharmacol Ther; 1994 Dec; 17(6):447-54. PubMed ID: 7707490
[TBL] [Abstract][Full Text] [Related]
25. Determination of ketoprofen enantiomers in human serum by capillary zone electrophoresis: man pharmacokinetic studies after administration of rac-ketoprofen tablets.
Główka FK
J Pharm Biomed Anal; 2002 Nov; 30(4):1035-45. PubMed ID: 12408894
[TBL] [Abstract][Full Text] [Related]
26. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.
Hayball PJ; Nation RL; Bochner F; Sansom LN; Ahern MJ; Smith MD
Br J Clin Pharmacol; 1993 Sep; 36(3):185-93. PubMed ID: 9114902
[TBL] [Abstract][Full Text] [Related]
27. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
Brink P; DeGraves F; Ravis WR; Johansen D; Campbell JD; Duran SH
Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
[TBL] [Abstract][Full Text] [Related]
28. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
van Haeringen NJ; van Sorge AA; Van Delft JL; Carballosa Coré-Bodelier VM
J Ocul Pharmacol Ther; 2000 Aug; 16(4):345-52. PubMed ID: 10977130
[TBL] [Abstract][Full Text] [Related]
29. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
[TBL] [Abstract][Full Text] [Related]
30. High performance capillary electrophoresis for determination of the enantiomers of 2-arylpropionic acid derivatives in human serum. Pharmacokinetic studies of ketoprofen enantiomers following administration of standard and sustained release tablets.
Główka FK; Karaźniewicz M
J Pharm Biomed Anal; 2004 Jun; 35(4):807-16. PubMed ID: 15193725
[TBL] [Abstract][Full Text] [Related]
31. Oral bioavailability and pharmacokinetic characteristics of ketoprofen enantiomers after oral and intravenous administration in Asian elephants (Elephas maximus).
Hunter RP; Isaza R; Koch DE
Am J Vet Res; 2003 Jan; 64(1):109-14. PubMed ID: 12518887
[TBL] [Abstract][Full Text] [Related]
32. Influence of oxytetracycline on carprofen pharmacodynamics and pharmacokinetics in calves.
Brentnall C; Cheng Z; McKellar QA; Lees P
J Vet Pharmacol Ther; 2013 Aug; 36(4):320-8. PubMed ID: 22913421
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats.
Sidhu PK; Landoni MF; Lees P
Res Vet Sci; 2006 Feb; 80(1):79-90. PubMed ID: 16005916
[TBL] [Abstract][Full Text] [Related]
34. A pharmacodynamic and pharmacokinetic study with vedaprofen in an equine model of acute nonimmune inflammation.
Lees P; May SA; Hoeijmakers M; Coert A; Rens PV
J Vet Pharmacol Ther; 1999 Apr; 22(2):96-106. PubMed ID: 10372594
[TBL] [Abstract][Full Text] [Related]
35. Analgesia and COX-2 inhibition.
Dionne RA; Khan AA; Gordon SM
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S63-70. PubMed ID: 11695255
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacodynamics of flunixin, ketoprofen and tolfenamic acid in calves.
Landoni MF; Cunningham FM; Lees P
Vet Rec; 1995 Oct; 137(17):428-31. PubMed ID: 8560701
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of PGE2 production by nimesulide compared with diclofenac in the acutely inflamed joint of patients with arthritis.
Duffy T; Belton O; Bresnihan B; FitzGerald O; FitzGerald D
Drugs; 2003; 63 Suppl 1():31-6. PubMed ID: 14506909
[TBL] [Abstract][Full Text] [Related]
38. Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid.
Oelkers R; Neupert W; Williams KM; Brune K; Geisslinger G
Br J Clin Pharmacol; 1997 Feb; 43(2):145-53. PubMed ID: 9131946
[TBL] [Abstract][Full Text] [Related]
39. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-inda none (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases.
Panara MR; Greco A; Santini G; Sciulli MG; Rotondo MT; Padovano R; di Giamberardino M; Cipollone F; Cuccurullo F; Patrono C
Br J Pharmacol; 1995 Nov; 116(5):2429-34. PubMed ID: 8581280
[TBL] [Abstract][Full Text] [Related]
40. Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants.
Moses VS; Hardy J; Bertone AL; Weisbrode SE
Am J Vet Res; 2001 Jan; 62(1):54-60. PubMed ID: 11197561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
